Infliximab Eligibility checklist and clinical pathway
treatment of active non-infectious sight threatening uveitis in paediatric patients who have ongoing sight threatening complications with treatment with adalimumab SC or
treatment of active non-infectious sight threatening uveitis in paediatric patients who have ongoing sight threatening complications with treatment with adalimumab SC or